Technology · Health & biomedicine / Therapeutics & platforms

Therapeutic vaccines (cancer and chronic disease)

Vaccines given to treat an existing disease — antigen-specific DNA, mRNA or cell-based products — with one approved cell-based product since 2010 and a cancer-vaccine market valued at USD 10.21 billion in 2023.

Maturity 6/9 Risk: high Pharma & biologics Advanced therapies US · CN · EU verified 2026-10-16 · 6 Sources

1 · What it gives

Therapeutic vaccines treat a disease that is already present, with high specificity, fewer side effects and potentially longer-lasting effect and no drug resistance compared with chemical or other biological drugs. Sipuleucel-T (Provenge), approved by the FDA in 2010, is the commercial-scale example. The global cancer-vaccine market was valued at USD 10.21 billion in 2023 and is projected to reach USD 30.16 billion by 2033.

2 · What it replaces 6

D2	On-farm culture, PCR panels, rapid tests and veterinary laboratory services for livestock and aquaculture — treat what is diagnosed instead of blanket and prophylactic antibiotic treatment Replaces: Blanket treatment of every clinical mastitis case, group metaphylaxis on suspicion, prophylactic antibiotics in hatcheries and ponds, …	DIAG
D0	Bacteriophage therapy for bacterial disease in fish and shrimp farming instead of medicated-feed antibiotics Replaces: Antibiotics in medicated feed and bath treatments - oxytetracycline, florfenicol, oxolinic acid, enrofloxacin, sulfonamide-trimethoprim …	VET
D1	Bio-based and soil-biodegradable plastics instead of fossil commodity plastics (PET, LDPE, PS) and their microplastics Replaces: Fossil polyethylene/polypropylene/PS/PET in flexible and rigid packaging; intentional microplastics (restricted in the EU since 2023); …	PACK
D2	Crop disease forecasting models, spore traps, pheromone and smart pest traps and field diagnostics — spray when risk is real instead of calendar-based fungicide and insecticide programmes Replaces: Fixed-interval ("calendar") protective fungicide sprays and routine insecticide applications regardless of pest pressure	EAC
D1	Fermentation (stainless and single-use bioreactors, solid-state reactors) and downstream equipment (centrifuges, filtration, spray and fluid-bed drying, formulation) for local production of enzymes, microbial products and fermentation ingredients instead of chemical-synthesis plants and imports Replaces: Chemical-synthesis routes and imports for the products in FI-, FD-, I- and A-series articles (enzymes, organic acids, vitamins, microbial …	EAC
D1	Fermentation and plant-derived sweeteners instead of aspartame, saccharin and sucralose Replaces: Artificial high-intensity sweeteners — aspartame (IARC 2B since 2023), saccharin, sucralose, acesulfame-K in beverages and dairy; part of …	FOOD

3 · How to implement 4 steps

1
Identify antigens
Identify the specific antigens to target.
2
Design the vaccine
Design the vaccine as DNA, mRNA or a cell-based product.
3
GMP manufacturing
Manufacture under GMP conditions.
4
Clinical trials
Run clinical trials to establish safety, dosage and efficacy.

4 · Who delivers

Matched suppliers (matched automatically)

Vaxxinova Norway	Norway	Not classified	active
Esco Aster	Singapore	Services / consulting	active
EGAVET	Egypt	Research / RTO	active
Avani	Indonesia	Producer	active
Liselo Labs	South Africa	Research / RTO	active
MSD Animal Health Poultry and Swine Sub Sahara Africa	South Africa	Services / consulting	active
Biocamp Laboratórios Ltda	Brazil	Research / RTO	active
Abtec	India	Research / RTO	active
Aristogene Biosciences Pvt. Ltd.	India	Producer	active
EcoFix Kenya Ltd (EFK)	Kenya	Producer	active
PT. Central Proteina Prima, Tbk	Indonesia	Producer	active
Vland Biotech 蔚蓝生物 (SSE 603739)	China	Research / RTO	active

Leading companies and institutes (from the brief)

Companies and institutions developing or delivering therapeutic vaccines in the sources: Genoa Biotechnologia, CreaGene, Northwest Biotherapeutics, APAC Biotech, Merck & Co., SK Bioscience and GlaxoSmithKline.

5 · Rules & route to market

Route into Russia / EAEU: DIAG · Rosselkhoznadzor
expert examination up to 70 working days plus registration steps
Information, not legal advice — confirm the procedure for your product. (2026-10-06)

United States

In the US the FDA regulates these products.

European Union

The sources reviewed on 2026-10-16 identified no the EU regulator or standard specific to this technology. Treat the route as case-by-case and ask for a check.

China

In China the NMPA Center for Drug Evaluation (CDE) oversees regulation.

6 · Money: tenders & grants

Tender	Czechia – Immunosuppressive agents – Selektivní Imunosupresiva - Eculizumab IV. Institut klinické a experimentální medicíny · Czechia	Oct 20, 2026 4 days
Tender	Czechia – Immunosuppressive agents – Takrolimus 1x denně - LP ADVAGRAF Institut klinické a experimentální medicíny · Czechia	Oct 20, 2026 4 days
Tender	Netherlands – Influenza vaccines – Trivalent Influenza Vaccines 2026 Rijksinstituut voor Volksgezondheid en Milieu (RIVM), RIVM · Netherlands	Oct 19, 2026 3 days
Grant	Advancing sustainable maintenance and repair measures for existing buildings European Commission · EU	Dec 1, 2026 46 days
Grant	Capacity building for extending product lifecycles through repair and refurbishment European Commission · EU	Sep 22, 2027 341 days
Grant	Enhancing ecodesign and circularity of construction products European Commission · EU	Sep 22, 2027 341 days
Grant	Health of ecosystems and wild species, predictions and impacts on human health, in the face of existing and … European Commission · EU	Sep 22, 2027 341 days
Grant	Replacing hazardous substances in biocidal products European Commission · EU	Sep 22, 2027 341 days

7 · Tech stack & innovations

Main risks from the sources: manufacturing complexity of personalised products, high production cost, immune-related toxicity, and the lack of standardised regulatory frameworks or global harmonisation.

Sources 6

Acrpnet.org — acrpnet.org 2026-10-16
Pmc.ncbi.nlm.nih.gov — pmc.ncbi.nlm.nih.gov 2026-10-16
Mdpi.com — www.mdpi.com 2026-10-16
Pharmews.xyz — www.pharmews.xyz 2026-10-16
Pmc.ncbi.nlm.nih.gov — pmc.ncbi.nlm.nih.gov 2026-10-16
Pmc.ncbi.nlm.nih.gov — pmc.ncbi.nlm.nih.gov 2026-10-16